These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 9016863)
1. Abnormal collagen binding activity of 2A von Willebrand factor: evidence that the defect depends only on the lack of large multimers. Casonato A; Pontara E; Bertomoro A; Zucchetto S; Zerbinati P; Girolami A J Lab Clin Med; 1997 Feb; 129(2):251-9. PubMed ID: 9016863 [TBL] [Abstract][Full Text] [Related]
2. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications. Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235 [TBL] [Abstract][Full Text] [Related]
3. Different organization of von Willebrand factor oligomers in type-2A and -2B von Willebrand disease variants: effects of DDAVP infusion and protease inhibitors. Casonato A; Pontara E; Bertomoro A; Dannhauser D; Secchiero S; Zaninotto M; Girolami A Ann Hematol; 1995 Oct; 71(4):189-94. PubMed ID: 7578526 [TBL] [Abstract][Full Text] [Related]
4. Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity? Casonato A; Pontara E; Bertomoro A; Sartorello F; Cattini MG; Girolami A Br J Haematol; 2001 Mar; 112(3):578-83. PubMed ID: 11260057 [TBL] [Abstract][Full Text] [Related]
5. Effect of desmopressin on von Willebrand factor multimers in Doberman Pinschers with type 1 von Willebrand disease. Callan MB; Giger U; Catalfamo JL Am J Vet Res; 2005 May; 66(5):861-7. PubMed ID: 15938072 [TBL] [Abstract][Full Text] [Related]
6. A probable double heterozygous type II von Willebrand's disease with increased ristocetin induced platelet aggregation. Kinoshita S; Yoshioka K; Kasahara M; Takamiya O Am J Hematol; 1992 Jul; 40(3):192-8. PubMed ID: 1609773 [TBL] [Abstract][Full Text] [Related]
8. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers. Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268 [TBL] [Abstract][Full Text] [Related]
9. Type 2M von Willebrand disease variant characterized by abnormal von willebrand factor multimerization. Casonato A; Pontara E; Sartorello F; Bertomoro A; Durante C; Girolami A J Lab Clin Med; 2001 Jan; 137(1):70-6. PubMed ID: 11150026 [TBL] [Abstract][Full Text] [Related]
10. The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitors. Batlle J; Lopez Fernandez MF; Campos M; Justica B; Berges C; Navarro JL; Diaz Cremades JM; Kasper CK; Dent JA; Ruggeri ZM Blood; 1986 Dec; 68(6):1207-12. PubMed ID: 3490883 [TBL] [Abstract][Full Text] [Related]
11. von Willebrand's disease: use of collagen binding assay provides potential improvement to laboratory monitoring of desmopressin (DDAVP) therapy. Favaloro EJ; Dean M; Grispo L; Exner T; Koutts J Am J Hematol; 1994 Mar; 45(3):205-11. PubMed ID: 8296790 [TBL] [Abstract][Full Text] [Related]
12. Platelet--von Willebrand factor interactions in type IIB von Willebrand's disease. Holmberg L; Kristoffersson AC; Lamme S; Nilsson IM; Awidi A; Solum NO Scand J Haematol; 1985 Sep; 35(3):305-14. PubMed ID: 3877338 [TBL] [Abstract][Full Text] [Related]
13. DDAVP in type IIa von Willebrand's disease. Gralnick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y Blood; 1986 Feb; 67(2):465-8. PubMed ID: 3080040 [TBL] [Abstract][Full Text] [Related]
14. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio. Gadisseur A; Berneman Z; Schroyens W; Michiels JJ Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359 [TBL] [Abstract][Full Text] [Related]
15. A new candidate mutation, G1629R, in a patient with type 2A von Willebrand's disease: basic mechanisms and clinical implications. Hilbert L; Federici AB; Baronciani L; Dallagiovanna S; Mazurier C Haematologica; 2004 Sep; 89(9):1128-33. PubMed ID: 15377475 [TBL] [Abstract][Full Text] [Related]
16. Impaired release of tissue plasminogen activator (t-PA) following DDAVP infusion in von Willebrand's disease with low platelet von Willebrand factor content. Casonato A; Sartori MT; Pontara E; Zucchetto A; Dannhäuser D; Patrassi G; Girolami A Blood Coagul Fibrinolysis; 1992 Apr; 3(2):149-53. PubMed ID: 1606286 [TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor. Mannucci PM; Lombardi R; Bader R; Vianello L; Federici AB; Solinas S; Mazzucconi MG; Mariani G Blood; 1985 Oct; 66(4):796-802. PubMed ID: 3876122 [TBL] [Abstract][Full Text] [Related]
18. The von Willebrand factor collagen-binding activity assay: clinical application. Kallas A; Talpsep T Ann Hematol; 2001 Aug; 80(8):466-71. PubMed ID: 11563592 [TBL] [Abstract][Full Text] [Related]
19. Response to desmopressin in type IID von Willebrand's disease. Thomas N; O'Callaghan U; Lowe GD; Olszynski V; Kernoff PB; Abildgaard CF; Tuddenham EG Clin Lab Haematol; 1989; 11(3):189-97. PubMed ID: 2591151 [TBL] [Abstract][Full Text] [Related]
20. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1. Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]